Possibly, but not automatically. Life insurers set rate classes partly on height and weight, blood pressure, cholesterol and blood sugar, so lower weight and better numbers can move you to a better class. You can ask your current insurer to reconsider your rating or apply for a new policy; either way expect new medical evidence, a look at your weight history, and questions about your GLP-1, which you must answer honestly.
Last updated: 2026-10-01 · First published: 2026-10-01 · Sources: Munich Re, Gen Re, RGA, SC Department of Insurance · all checked Oct 2026
Through rate classes. When you apply, the insurer's underwriters compare your height and weight (your "build", usually expressed as BMI) with charts that set bands for each class, from the best "preferred" classes down to standard and "rated" policies, which cost extra to cover extra risk (Florida Department of Financial Services consumer guide, checked Oct 2026). Gen Re, a reinsurer, writes that BMI is "the measure most often used" for unhealthy weight in underwriting, and that it matters to read it together with blood pressure, blood lipids and blood sugar (Gen Re, April 2025, checked Oct 2026).
The other markers count too. Swiss Re describes giving "credits" or "debits" for waist size and metabolic health markers, and Munich Re's risk calculator looks at build, blood pressure, lipids, blood glucose and heart screening together (Swiss Re, February 2025; Munich Re Life Science Report 2025; checked Oct 2026). So a lower weight helps most when your blood pressure, cholesterol and A1c have improved with it.
Recent weight loss is often only partly counted. Gen Re's rule for a significant loss (more than 5% of body weight) in the past year is to average your weight before and after, so "half of the recently achieved weight loss" counts; Hannover Re says UK practice also typically recognizes about half (Gen Re, April 2025; Hannover Re UK, 2026; checked Oct 2026).
You can ask, and some insurers have a form for it. Pacific Life's policy change form, for example, has boxes to "reduce or remove" a table rating or "change to the best available risk class", says evidence of insurability is required for risk class changes, and warns that sending it "does not guarantee approval" (Pacific Life form, February 2025, checked Oct 2026). Call your insurer and ask what it needs: typically new medical information such as an exam or labs.
The other route is to shop a new policy. RGA, a reinsurer, notes that people who have lost a lot of weight "may lapse their rated policies and re-enter with better terms", and that insurers will look at your BMI history, not just your weight on the day you apply (RGA, November 2025, checked Oct 2026). Two cautions: a new policy starts a new two-year contestability period (South Carolina Department of Insurance, checked Oct 2026), and you should keep the old policy in force until the new one is issued.
What underwriters want to see, as far as reinsurers have published it: Munich Re lists the duration of treatment, other health conditions, side effects and "weight trends over time", and calls post-treatment weight stability ideal; RGA says applicants with well-documented, physician-monitored treatment and stable clinical numbers "may present a favorable risk profile" (Munich Re Life Science Report 2025; RGA, November 2025; checked Oct 2026). None of these sources sets a fixed number of months your weight must be stable, so ask the insurer. A record of your weigh-ins helps; the 16-week maintain plan keeps one.
Munich Re, a reinsurer (it insures the insurers), wrote in February 2026 that GLP-1 benefits to underwriting "extend beyond improved ratings for those currently qualifying at substandard rates" and "may also expand insurability for individuals currently viewed as uninsurable". It expects electronic health records, with lab results and prescription histories, to be "vital" for judging metabolic risk (Munich Re, February 2026, checked Oct 2026).
It also flags the catch: people who reach their goal may stop the drug, and "this could result in rebound weight gain" (same article). Its April 2026 FAQ adds that persistence and compliance must be weighed in long-term outcomes. A reinsurer's view is not a rate quote; each insurer applies its own rules. For what the trials show after stopping, see regain after Wegovy or Zepbound.
Yes. Answer every medication and weight question on the application truthfully, including a GLP-1 prescription and the weight you started at.
One short email a week on GLP-1 treatment: what the trials and prescribing labels describe at each stage, and changes in cost and access. General information, not tied to a particular medication or dose. For the trial average for your own medication, use the curve calculator.
No spam. Unsubscribe any time. Educational information only, not medical advice.
Embody · from $69/mowith one-year prepay ($828 upfront)
Check price →